Pharmafile Logo
Pharmafocus logo
Advanced Search

AZ’s latest purchase fails to impress investors

April 25, 2007
Sales and Marketing

AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the £15.6 billion …

News

Clinical trial news from Datamonitor

April 18, 2007
Research and Development

Array BioPharma receives payment for cancer inhibitorArray BioPharma has received a $2 million milestone payment from AstraZeneca after its MEK …

News

Product news roundup from Datamonitor

April 18, 2007
Sales and Marketing

Changing of the guard in HIV treatmentThe HIV market is forecast to grow from $7.1 billion in 2005 to an …

News

Lilly upbeat after strong start to year

April 18, 2007
Sales and Marketing

Stronger than expected sales and profits in early 2007 has lifted Lilly, prompting the US pharma company to raise its …

News

Public to get clearer picture of hospital bugs

April 18, 2007
NHS

 The government is to turn up the heat on trusts over rising levels of hospital infections by showing the public …

News

Diabetes drug costs double in five years

April 18, 2007
Sales and Marketing

A growing number of patients and a switch to newer medicines has brought about a doubling of England's spending on …

News

Athena wins two Pfizer accounts

April 18, 2007
Medical Communications

Athena Medical PR has been appointed by Pfizer UK to run its PR campaigns for two of its anti-infective products: …

News

Europe’s buoyant biotech set for further growth

April 16, 2007
Research and Development, Sales and Marketing biotech

A new comprehensive survey of the world's biotechnology industry shows the sector to be in great health, with indications of …

News

NICE in the dock: what the judicial review means for pharma

April 16, 2007
Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review

The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …

Feature

Product news from Datamonitor

April 16, 2007
Research and Development, Sales and Marketing

Carrington Laboratories to manufacture sublingual vaccinesCarrington Laboratories has reported that its subsidiary DelSite Biotechnologies has entered into an agreement with …

News

Company news from Datamonitor

April 16, 2007
Sales and Marketing

Avenir plans restructure and ends AZ collaborationsAvanir Pharmaceuticals has said it plans to implement a restructuring plan and has ended …

News

NHS will be ‘unrecognisable’ in 10 years’ time, say doctors

April 16, 2007
NHS

Most young doctors believe the NHS will be unrecognisable in 10 years' time, a new survey has revealed.The research, published …

News

Europe imposes restrictions on Ketek prescribing

April 16, 2007
Sales and Marketing Ketek, safety

The European Medicines Agency has issued guidance for the four indications of Ketek, the Sanofi-Aventis antibiotic stripped of several indications …

News

Encouraging New Thinking in Strategic Planning

April 12, 2007
Sales and Marketing marketing, planning, strategic planning, strategy

How many pharma marketers, faced with the annual chore of writing a strategic plan, have decided not to take the …

Feature

Product Development Update

April 12, 2007
Research and Development, Sales and Marketing

Product news round-up from Datamonitor ChemGenex begins CML trialChemGenex Pharmaceutical has treated the first patient in a new phase II/III clinical …

News

Change in US law could cut drugs spending by $30 billion

April 12, 2007
Sales and Marketing US, reform

Calls to allow the US government to negotiate drug prices with the pharmaceutical industry have been reawakened by a new …

News

Abbott lowers prices on HIV drugs

April 12, 2007
Sales and Marketing HIV, par

Intervention from the World Health Organisation has spurred Abbott to lower its prices on HIV drugs in developing countries.The company …

News

Resolute to open New York office

April 12, 2007
Medical Communications Resolute

London-based healthcare consultancy Resolute is to break into the all-important US market by opening an office in New York.Resolute was …

News

Sales representatives blow the whistle on rule-breaking call rates

April 11, 2007
Sales and Marketing ABPI, ethics

Pharmaceutical sales representatives are turning to the industry regulator and blowing the whistle on their own companies, when they are …

News

Novartis’ Zelnorm pulled from market after safety concerns

April 2, 2007
Sales and Marketing FDA, reg

Zelnorm, the treatment for irritable bowel syndrome, has been withdrawn from the US market after the FDA raised concerns about …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025